Herbal Therapies and "Smart" Drugs

I. General Concerns
A. Lack of regulation
1. Review FDA drug development
sequence
2. Safety, efficacy
B. Variability - dose, purity, potency
II. "Smart" Drugs
- nootropics; "noos" = mind, "tropin" = to bend/turn
- cognitive enhancers
A. General Strategy
1. Neurotransmitter support -
precursors, cofactors
2. Nutritional support - amino acids,
nutrients, herbs
3. drugs
B. Representative Examples
1. Piracetam
a. increase
membrane permeability
b. speeds up
interhemispheric flow of information
c. increases
Ach receptor density in frontal cortex
d. increases
NMDA receptor density in hippocampus
2. Gingko Biloba - Egb-761
a.
antioxidant effects - scavenge free radicals implicated in Alzheimer's
b. empirical
results mixed
c. most doses
in commercial drinks at placebo level
3. Ginseng - HT1001
a. effects on
Ach - blocks amnestic effects of scopolamine (in rats)
- improved learning in rats with frontal damage
b. adaptogen
and aphrodisiac
III. Herbal treatment of
disorders
A. St. John's Wort - hypericum
1. treats mild-moderate depression
2. mechanisms of action - reuptake
blockade (5-HT, DA, NE)
- binds to GABA (bzd) receptors
- NMDA receptors
- long term effects to increase 5-HT receptor density
3. efficacy - mixed, generally
effective in mild cases
B. Valerian - anxiolytic, hypnotic
1. mechanisms of action - GABA
agonist at bzd receptor (pass BBB?)
- 5-HT1a agonist
2. efficacy mixed
3. side effects include liver
toxicity, interacts with alcohol, SSRIs
C. Kava
1. mechanisms of action - GABA
agonist at bzd receptor
2. efficacy and side effects (similar
to valerian)